SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-16-065775
Filing Date
2016-05-16
Accepted
2016-05-16 17:01:18
Documents
42
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 ONCOCYTE CORPORATION 10-Q 3-31-2016 form10q.htm 10-Q 319582
2 EXHIBIT 31 ex31.htm EX-31 12954
3 EXHIBIT 32 ex32.htm EX-32 4452
  Complete submission text file 0001140361-16-065775.txt   2092222

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ocx-20160331.xml EX-101.INS 293726
5 XBRL TAXONOMY EXTENSION SCHEMA ocx-20160331.xsd EX-101.SCH 23163
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocx-20160331_cal.xml EX-101.CAL 31837
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocx-20160331_def.xml EX-101.DEF 74440
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocx-20160331_lab.xml EX-101.LAB 317421
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocx-20160331_pre.xml EX-101.PRE 174614
Mailing Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502 510-521-3390
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 161654870
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences